Blaine Davis

Blaine Davis has a significant background in finance and leadership roles within the pharmaceutical and healthcare industry. Blaine'smost recent position was as the Chief Financial Officer at Cartesian Therapeutics starting in November 2023. Prior to that, they served as the Chief Financial Officer at Selecta Biosciences from November 2022 to January 2024 and at Protara Therapeutics from February 2020 to July 2022. Furthermore, Davis worked at Insmed Incorporated as the Head of Investor Relations and Corporate Communications from July 2017 to February 2020. Blaine also has experience as the President of PPD Consulting LLC from February 2017 to January 2020, providing strategic and operational consulting services in the healthcare sector. Additionally, they held various roles at Endo Pharmaceuticals and Endo International, including Senior Vice President and President, respectively, responsible for business operations, international ventures, and investor relations. Davis began their career at BMS, where they fulfilled roles in business development and investor relations.

Blaine Davis attended Middlebury College from 1992 to 1996, where they earned a Bachelor of Science degree in Biology, Psychology, and Economics.